Texas A&M researcher explains how embryo fights retroviral infectionJune 25, 2010
The work of the researcher was recently published in Cell Stem Cell.
Early mammalian embryos actually possess three stem cell lineages: ES (embryonic stem), TS (trophectoderm stem), and XEN (extraembryonic endoderm), which give rise to the fetus, placenta and yolk sac respectively, the Texas A&M researcher explains. Using the mouse as a model organism, Golding and his colleagues demonstrate that the mechanisms silencing gene expression are different between each of the three stem cell types.
"Much like a closed book cannot be read while an open book can, the DNA encoding genes can either be tightly wound up and silent or in a relaxed, open, active state," Golding explains. "The mechanisms that control this gene packaging are called epigenetic as they represent a level of regulation that is above or 'epi' to genetics."
The study shows "retroviral silencing in XEN cells is epigenetic in origin" and that "the three cell lineages of early mammalian embryo have vastly different viral silencing strategies as well as different capacities to suppress retroviral activity."
To examine the validity of a common assumption that these stem cells use similar mechanisms to silence retroviruses, Golding infected the mouse embryo stem cells with mouse leukemia virus (MLV) and monitored the virus' activity.
ES cells showed a progressive decline in virus activity, while TS cells had a constant level of virus activity. XEN cells, however, exhibited extremely aggressive and rapid silencing of virus activity, according to the study.
"Epigenetics is an exciting new field of research which is altering the way we think about fetal nutrition and exposure to environmental chemicals," Golding adds. "This discovery that all three stem cell types of the early embryo utilize slightly different mechanisms to control gene expression has profound implications for how we diagnose and treat fetal diseases."
Texas A&M University
Related Retroviral Current Events and Retroviral News Articles
International experts call for an end to preventable deaths from acute kidney injury by 2025
Preventable deaths caused by acute kidney injury (AKI) could be nearly eliminated in just 10 years, according to leading medical experts.
New protein booster may lead to better DNA vaccines and gene therapy
Scientists have discovered a new way to manipulate how cells function, a finding that might help advance an experimental approach to improving public health: DNA vaccines, which could be more efficient, less expensive and easier to store than traditional vaccines.
Fewer viral relics may be due to a less bloody evolutionary history
A researcher from Plymouth University School of Biomedical and Healthcare Sciences had led an international team investigating viruses that entered the DNA of our ancestors millions of years ago.
Dramatic decline in risk for heart attacks among HIV-positive Kaiser Permanente members
Previously reported increased risk of heart attacks among HIV-positive individuals has been largely reversed in recent years for Kaiser Permanente's California patients, according to a study published in the current online issue of Clinical Infectious Diseases.
Scientists identify new and beneficial function of endogenous retroviruses in immune response
Retroviruses are best known for causing contagious scourges such as AIDS, or more sporadically, cancer.
Hepatitis C ruled out as cause of mental impairment in HIV patients
Advances in treatment for human immunodeficiency virus (HIV) have made it possible for people with HIV to survive much longer.
Masking HIV target cells prevents viral transmission in animal model
Cloaking immune cells with antibodies that block T cell trafficking to the gut can substantially reduce the risk of viral transmission in a non-human primate model of HIV infection, scientists report.
Koala study reveals clues about origins of the human genome
Eight percent of your genome derives from retroviruses that inserted themselves into human sex cells millions of years ago. Right now the koala retrovirus (KoRV) is invading koala genomes, a process that can help us understand our own viral lineage and make decisions about managing this vulnerable species.
Researchers show irradiation plus transplantation effective for treating HIV/AIDS
Yerkes National Primate Research Center researchers are the first to show that an irradiation plus transplantation combination approach in nonhuman primates can be used to treat or even possibly cure HIV/AIDS, and this new model is providing some answers about the "Berlin patient," the only human thought cured of AIDS.
'Prepped' by tumor cells, lymphatic cells encourage breast cancer cells to spread
Breast cancer cells can lay the groundwork for their own spread throughout the body by coaxing cells within lymphatic vessels to send out tumor-welcoming signals, according to a new report by Johns Hopkins scientists.
More Retroviral Current Events and Retroviral News Articles